Haisco Pharmaceutical Group Co., Ltd.
002653
Kedudukan dalam Saham
#2082
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Harga Saham
$8.64
Modal Pasaran
$9.85B
Perubahan (1 hari)
4.34%
Perubahan (1 tahun)
18.80%
Negara
CN
Perdagangan Haisco Pharmaceutical Group Co., Ltd. (002653)
Kategori
Healthcare
EPS untuk Haisco Pharmaceutical Group Co., Ltd. (002653)
EPS setakat June 2026 TTM: $0.13
Menurut laporan kewangan terkini dan harga saham Haisco Pharmaceutical Group Co., Ltd., EPS semasa syarikat (TTM) adalah $0.13. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $0.04 sama dengan EPS tahun 2022 iaitu $0.04.
Sejarah EPS untuk Haisco Pharmaceutical Group Co., Ltd. dari 2008 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $0.13 | 155.00% |
| 2024 | $0.05 | 27.03% |
| 2023 | $0.04 | 2.14% |
| 2022 | $0.04 | -25.99% |
| 2021 | $0.05 | -44.68% |
| 2020 | $0.09 | 37.82% |
| 2019 | $0.07 | 46.56% |
| 2018 | $0.05 | 33.43% |
| 2017 | $0.03 | -42.81% |
| 2016 | $0.06 | 9.65% |
| 2015 | $0.05 | -20.50% |
| 2014 | $0.07 | -14.29% |
| 2013 | $0.08 | 20.40% |
| 2012 | $0.07 | 29.33% |
| 2011 | $0.05 | 4.74% |
| 2010 | $0.05 | 6.83% |
| 2009 | $0.05 | 47.40% |
| 2008 | $0.03 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| $17.32 | 13,484.31% |
US
|
|
| $-7.98 | -6,358.82% |
US
|
|
| $-5.29 | -4,249.02% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 21,656.86% |
NL
|
